AI-powered data analytics has evolved from a supporting function into the backbone of modern brand strategy and decision-making.
Luke Greenwalt
Advertisement
VP, U.S. Thought Leadership & Innovation, IQVIA
Articles by Luke Greenwalt
Amid converging pharma pricing trends, such as those triggered by the Inflation Reduction Act, companies must adopt novel operational practices and strategic approaches in line with new parameters for success across a product’s lifecycle.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
What 10 Years of Clinical Research Growth in Puerto Rico Have Taught Us
2
Parabilis Medicines Raises $670 Million in Initial Public Offering
3
The Regulatory Landscape for Rare Pediatric Diseases
4
CMS ACCESS Model: Changing the Landscape of Disease Management
5